blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1755581

EP1755581 - METHODS AND COMPOSITIONS FOR THE TREATMENT OF MYOCARDIAL CONDITIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.05.2016
Database last updated on 28.03.2026
Most recent event   Tooltip17.08.2018Lapse of the patent in a contracting state
New state(s): BG		published on 19.09.2018  [2018/38]
Applicant(s)For all designated states
Northern Sydney Local Health District
NSLHD Executive Office, Building 51
Royal North Shore Hospital
Reserve Road
St. Leonards, NSW 2065 / AU
[2015/28]
Former [2007/09]For all designated states
Northern Sydney and Central Coast Area Health Service
Executive Offices Gosford Hospital Holden Street
Gosford NSW 2250 / AU
Inventor(s)01 / RASMUSSEN, Helge, H.
29 Mosman Street
Mosman, NSW 2088 / AU
02 / BUNDGAARD, Henning
Arnevangen 1
DK-2840 Holte / DK
 [2007/09]
Representative(s)Ryan, Anne Mary, et al
Anne Ryan & Co
2 Crofton Terrace
Dun Laoghaire, County Dublin A96 V6P7 / IE
[N/P]
Former [2015/29]Ryan, Anne Mary, et al
Anne Ryan & Co.
60 Northumberland Road
Ballsbridge
Dublin 4 / IE
Former [2007/09]Ryan, Anne Mary, et al
c/o Anne Ryan & Co. 60 Northumberland Road Ballsbridge
Dublin 4 / IE
Application number, filing date05735674.326.04.2005
[2007/09]
WO2005AU00590
Priority number, dateAU2004090217923.04.2004         Original published format: AU 2004902179
[2007/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005102304
Date:03.11.2005
Language:EN
[2005/44]
Type: A1 Application with search report 
No.:EP1755581
Date:28.02.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 03.11.2005 takes the place of the publication of the European patent application.
[2007/09]
Type: B1 Patent specification 
No.:EP1755581
Date:15.07.2015
Language:EN
[2015/29]
Search report(s)International search report - published on:AU03.11.2005
(Supplementary) European search report - dispatched on:EP30.11.2007
ClassificationIPC:A61K31/195, A61K31/137, A61K31/138, A61P9/04
[2007/09]
CPC:
A61K31/137 (EP,US); A61K31/138 (EP,US); A61K31/195 (EP,US);
A61P43/00 (EP); A61P9/00 (EP); A61P9/04 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/29]
Former [2007/09]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON MYOKARDIALEN ERKRANKUNGEN[2007/09]
English:METHODS AND COMPOSITIONS FOR THE TREATMENT OF MYOCARDIAL CONDITIONS[2007/09]
French:METHODES ET COMPOSITIONS DE TRAITEMENT D'ETATS MYOCARDIQUES[2007/09]
Entry into regional phase26.10.2006National basic fee paid 
26.10.2006Search fee paid 
26.10.2006Designation fee(s) paid 
26.10.2006Examination fee paid 
Examination procedure23.02.2006Request for preliminary examination filed
International Preliminary Examining Authority: AU
31.10.2006Examination requested  [2007/09]
20.11.2009Despatch of a communication from the examining division (Time limit: M06)
26.05.2010Reply to a communication from the examining division
12.07.2011Despatch of a communication from the examining division (Time limit: M06)
08.05.2012Reply to a communication from the examining division
11.03.2013Despatch of a communication from the examining division (Time limit: M06)
18.10.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
13.12.2013Reply to a communication from the examining division
17.03.2014Despatch of a communication from the examining division (Time limit: M04)
02.07.2014Reply to a communication from the examining division
26.11.2014Communication of intention to grant the patent
20.03.2015Fee for grant paid
20.03.2015Fee for publishing/printing paid
20.03.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.11.2009
Opposition(s)18.04.2016No opposition filed within time limit [2016/25]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
13.12.2013Request for further processing filed
13.12.2013Full payment received (date of receipt of payment)
Request granted
03.01.2014Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
08.05.2012Request for further processing filed
08.05.2012Full payment received (date of receipt of payment)
Request granted
16.05.2012Decision despatched
Fees paidRenewal fee
12.04.2007Renewal fee patent year 03
26.09.2008Renewal fee patent year 04
26.05.2009Renewal fee patent year 05
27.04.2010Renewal fee patent year 06
26.04.2011Renewal fee patent year 07
27.04.2012Renewal fee patent year 08
25.04.2013Renewal fee patent year 09
25.03.2014Renewal fee patent year 10
28.04.2015Renewal fee patent year 11
Penalty fee
Additional fee for renewal fee
30.04.200804   M06   Fee paid on   26.09.2008
30.04.200905   M06   Fee paid on   26.05.2009
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU26.04.2005
AT15.07.2015
BE15.07.2015
BG15.07.2015
CY15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
FI15.07.2015
IS15.07.2015
LT15.07.2015
MC15.07.2015
NL15.07.2015
PL15.07.2015
PT15.07.2015
RO15.07.2015
SE15.07.2015
SI15.07.2015
SK15.07.2015
TR15.07.2015
GR16.10.2015
[2018/38]
Former [2018/32]HU26.04.2005
AT15.07.2015
BE15.07.2015
CY15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
FI15.07.2015
IS15.07.2015
LT15.07.2015
MC15.07.2015
NL15.07.2015
PL15.07.2015
PT15.07.2015
RO15.07.2015
SE15.07.2015
SI15.07.2015
SK15.07.2015
TR15.07.2015
GR16.10.2015
Former [2018/29]HU26.04.2005
AT15.07.2015
BE15.07.2015
CY15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
FI15.07.2015
IS15.07.2015
LT15.07.2015
MC15.07.2015
NL15.07.2015
PL15.07.2015
RO15.07.2015
SE15.07.2015
SI15.07.2015
SK15.07.2015
TR15.07.2015
GR16.10.2015
Former [2018/28]HU26.04.2005
AT15.07.2015
BE15.07.2015
CY15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
FI15.07.2015
IS15.07.2015
LT15.07.2015
MC15.07.2015
NL15.07.2015
PL15.07.2015
RO15.07.2015
SE15.07.2015
SI15.07.2015
SK15.07.2015
GR16.10.2015
Former [2017/40]AT15.07.2015
BE15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
FI15.07.2015
IS15.07.2015
LT15.07.2015
NL15.07.2015
PL15.07.2015
RO15.07.2015
SE15.07.2015
SI15.07.2015
SK15.07.2015
GR16.10.2015
Former [2017/03]AT15.07.2015
BE15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
FI15.07.2015
IS15.07.2015
LT15.07.2015
PL15.07.2015
RO15.07.2015
SE15.07.2015
SI15.07.2015
SK15.07.2015
GR16.10.2015
Former [2016/36]AT15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
FI15.07.2015
IS15.07.2015
LT15.07.2015
PL15.07.2015
RO15.07.2015
SE15.07.2015
SI15.07.2015
SK15.07.2015
GR16.10.2015
Former [2016/31]AT15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
FI15.07.2015
IS15.07.2015
LT15.07.2015
PL15.07.2015
RO15.07.2015
SE15.07.2015
SK15.07.2015
GR16.10.2015
Former [2016/23]AT15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
FI15.07.2015
LT15.07.2015
PL15.07.2015
RO15.07.2015
SE15.07.2015
SK15.07.2015
GR16.10.2015
Former [2016/22]AT15.07.2015
CZ15.07.2015
DK15.07.2015
EE15.07.2015
FI15.07.2015
LT15.07.2015
PL15.07.2015
SE15.07.2015
GR16.10.2015
Former [2016/20]AT15.07.2015
DK15.07.2015
FI15.07.2015
LT15.07.2015
PL15.07.2015
SE15.07.2015
GR16.10.2015
Former [2016/11]AT15.07.2015
FI15.07.2015
LT15.07.2015
PL15.07.2015
SE15.07.2015
GR16.10.2015
Former [2016/10]FI15.07.2015
LT15.07.2015
PL15.07.2015
SE15.07.2015
GR16.10.2015
Former [2016/09]FI15.07.2015
LT15.07.2015
GR16.10.2015
Former [2016/07]LT15.07.2015
Documents cited:Search[XY] WO02094820  (LILLY CO ELI et al.) [X] 1-5,15-25 * page 25, lines 1-23 *[Y] 6-14
 [XY] US2004053852  (STAMLER JONATHAN S et al.) [X] 1-5,15-25 * example I * * claims 4-6 *[Y] 8-14
 [XY] WO0018389  (US HEALTH et al.) [X] 1-5,15-25 * claim - *[Y] 8-14
 [XY] WO02087508  (NITROMED INC et al.) [X] 1-5,15-25 * page 2, lines 23-25 * * page 8, lines 8-13 *[Y] 8-14
 [XY] US6344474  (MARUANI JEANNE et al.) [X] 18,20-23 * column 7, lines 1-42 *[Y] 6
 [A]   HORINOUCHI TAKAHIRO ET AL: "Structure-activity relationship studies of (+-)-terbutaline and (+-)-fenoterol on beta3-adrenoceptors in the guinea pig gastric fundus", JOURNAL OF SMOOTH MUSCLE RESEARCH, vol. 37, no. 3-4, August 2001 (2001-08-01), pages 105 - 112, XP002458606, ISSN: 0916-8737 [A] 1-5,15-25 * abstract *

DOI:   http://dx.doi.org/10.1540/jsmr.37.105
 [A]   DE GROOT ANNEMIEKE A ET AL: "Involvement of the beta3 adrenoceptor in nebivolol-induced vasorelaxation in the rat aorta.", JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, vol. 42, no. 2, August 2003 (2003-08-01), pages 232 - 236, XP009092210, ISSN: 0160-2446 [A] 1-5,15-25 * abstract *

DOI:   http://dx.doi.org/10.1097/00005344-200308000-00012
 [Y]   CARSON P E: "Beta-blocker therapy in heart failure: pathophysiology and clinical results.", CURRENT PROBLEMS IN CARDIOLOGY JUL 1999, vol. 24, no. 7, July 1999 (1999-07-01), pages 421 - 460, XP002458608, ISSN: 0146-2806 [Y] 8-14 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0146-2806(99)90007-5
 [AY]   KOZLOVSKI V I ET AL: "EFFECTS OF TWO BETA3-AGONISTS, CGP 12177A AND BRL 37344, ON CORONARY FLOW AND CONTRACTILITY IN ISOLATED GUINEA PIG HEART", JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, NEW YORK, NY, US, vol. 41, no. 5, May 2003 (2003-05-01), pages 706 - 713, XP009056377, ISSN: 0160-2446 [A] 1-25 * abstract *[Y] 7

DOI:   http://dx.doi.org/10.1097/00005344-200305000-00006
 [A]   MONIOTTE S ET AL: "The [beta]3-adrenoceptor and its regulation in cardiac tissue", INTENSIVMEDIZIN UND NOTFALLMEDIZIN 2003 GERMANY, vol. 40, no. 6, 2003, pages 484 - 493, XP002458609, ISSN: 0175-3851 [A] 1-25 * page 490, column 1, paragraph L - column 2, paragraph L *

DOI:   http://dx.doi.org/10.1007/s00390-003-0317-z
 [A]   LOHSE M J ET AL: "What Is the Role of [beta]-Adrenergic Signaling in Heart Failure?", CIRCULATION RESEARCH 14 NOV 2003 UNITED STATES, vol. 93, no. 10, 14 November 2003 (2003-11-14), pages 896 - 906, XP002458610, ISSN: 0009-7330 [A] 1-25 * the whole document *

DOI:   http://dx.doi.org/10.1161/01.RES.0000102042.83024.CA
 [A]   CHENG HENG-JIE ET AL: "Functional significance of beta3-adrenergic receptor activation in heart failure", JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, vol. 33, no. 6, June 2001 (2001-06-01), & XVII ISHR WORLD CONGRESS OF THE INTERNATIONAL SOCIETY FOR HEART RESEARCH; WINNIPEG, CANADA; JULY 06-11, 2001, pages A20, XP002458611, ISSN: 0022-2828 [A] 1-25 * abstract *
International search[X] EP1145717  (PFIZER PROD INC et al.) [X]
 [X] WO0107025  (LILLY CO ELI et al.) [X]
 [X]   KARLE A. CHRISTOPHER ET AL: "Antiarrhytmic drug carvedilol inhibits HERG patassium channels.", CARDIOVASCULAR RESEARCH., vol. 49, no. 2, 2001, pages 361 - 370, XP008090670 [X]

DOI:   http://dx.doi.org/10.1016/S0008-6363(00)00265-0
 [X]   WHEELDON N.M. ET AL: "Cardiac effects of the beta 3-adrenoceptor agonist BRL35135 in man.", BR J CLIN PHARMAC., vol. 37, no. 4, 1994, pages 363 - 369, XP009092055 [X]
 [X]   CARSON PETER E. ET AL: "Beta-blocker therapy in heart failure: pathophysiology and clinical results.", CURRENT PROBLEMS IN CARDIOLOGY., vol. 24, no. 7, July 1999 (1999-07-01), pages 421 - 460, XP002458608 [X]

DOI:   http://dx.doi.org/10.1016/S0146-2806(99)90007-5
Examination  "Structures of some compounds mentioned in the application", 2 July 2014 (2014-07-02), XP055148438 [Y] 6-14
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.